3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
79
Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
5
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Breast Carcinoma In Situ
3
Arthralgia
3
Triple Negative Breast Neoplasms
2
Sexual Dysfunction, Physiological
1
Seizures
1
Recurrence
1
Pain
1
Osteoporosis
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Lethal Congenital Contracture Syndrome 2
1
Joint Diseases
1
Invasive Breast Cancer
1
Hypogonadism
1
Granulosa Cell Ovarian Cancer
1
Fractures, Bone
1
Erectile Dysfunction
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Metastatic
1
Advanced Metastatic Breast Cancer
1
Advanced Breast Carcinoma
1
Interventions
Prednisone
112
Docetaxel
87
Leuprolide
79
enzalutamide
72
Abiraterone Acetate
67
bicalutamide
53
Goserelin
50
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
42
Radiotherapy
39
abiraterone
28
Magnetic Resonance Spectroscopy
27
Gonadotropin-Releasing Hormone
24
gallium 68 PSMA-11
23
apalutamide
22
Androgen Antagonists
22
luprolide acetate gel depot
21
sipuleucel-T
20
Radiosurgery
20
Triptorelin Pamoate
18
cabazitaxel
17
cabozantinib
16
Radiotherapy, Intensity-Modulated
16
Flutamide
16
pembrolizumab
15
radium Ra 223 dichloride
14
Prednisolone
14
Nivolumab
14
Dutasteride
14
Dexamethasone
14
Radiation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostatic Neoplasms
×
Anastrozole
×
Clear all
No trials found.